Exagen Inc.
XGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.13 | 0.03 | -0.01 | -0.25 |
| FCF Yield | -18.48% | -43.46% | -88.94% | -12.19% |
| EV / EBITDA | -6.82 | -1.17 | -0.34 | -4.95 |
| Quality | ||||
| ROIC | -41.48% | -48.89% | -51.33% | -21.01% |
| Gross Margin | 59.51% | 56.06% | 46.86% | 57.37% |
| Cash Conversion Ratio | 0.88 | 0.61 | 0.68 | 0.75 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.89% | 2.85% | 2.77% | 6.14% |
| Free Cash Flow Growth | 9.78% | 58.07% | -61.06% | -55.71% |
| Safety | ||||
| Net Debt / EBITDA | -0.12 | 0.67 | 0.61 | 3.09 |
| Interest Coverage | -6.10 | -9.78 | -16.56 | -9.17 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 8.04 | 13.49 | 18.87 |
| Cash Conversion Cycle | -15.63 | 41.39 | 29.82 | 48.12 |